SON Stock Analysis: Sonoco Products | NYSE
Packaging & Containers | NYSE, USA | Market Cap: 5.684m USD | 12M Return: 28.9% | US8354951027 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 51.0M
EPS Trend: 56.2%
Qual. Beats: 0
Rev. Trend: 25.8%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Sonoco Products Company (NYSE: SON) is a global manufacturer of engineered and sustainable packaging products, operating across the United States, Europe, Canada, and the Asia Pacific. Founded in 1899 and headquartered in Hartsville, South Carolina, the company is classified within the GICS Materials sector under the Paper & Plastic Packaging Products & Materials sub-industry.
The business is organized into two reporting segments. The Consumer Packaging segment produces rigid paper, steel, and plastic containers, along with metal and peelable membrane ends, closures, and components. The Industrial Paper Packaging segment supplies paperboard tubes, cones, and cores, paper-based protective packaging, and uncoated recycled paperboards. Sonoco also distributes a broader range of packaging materials, including plastic, paper, and foam specialty products, serving diverse end markets such as food, construction, textiles, film, wire and cable, and general industrial applications.
Sonocos diversified segment structure and emphasis on sustainable packaging materials are consistent with broader trends in the global packaging industry, where manufacturers are balancing demand for fiber-based and recyclable solutions with cost pressures in paper and raw material inputs.
- Eviosys acquisition expands metal packaging footprint
- Consumer Packaging margins face steel and resin cost pressure
- Industrial Paper Packaging volumes weaken on construction and textile slowdown
| Net Income: 646.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 2.48 > 1.0 |
| NWC/Revenue: -0.19% < 20% (prev 10.83%; Δ -11.02% < -1%) |
| CFO/TA 0.06 > 3% & CFO 637.1m > Net Income 646.8m |
| Net Debt (4.80b) to EBITDA (1.55b): 3.10 < 3 |
| Current Ratio: 0.99 > 1.5 & < 3 |
| Outstanding Shares: last quarter (99.7m) vs 12m ago 0.30% < -2% |
| Gross Margin: 20.81% > 18% (prev 21.26%; Δ -0.45% > 0.5%) |
| Asset Turnover: 65.04% > 50% (prev 47.32%; Δ 17.72% > 0%) |
| Interest Coverage Ratio: 5.07 > 6 (EBIT TTM 1.03b / Interest Expense TTM 203.1m) |
| A: -0.00 (Total Current Assets 2.79b - Total Current Liabilities 2.80b) / Total Assets 11.0b |
| B: 0.31 (Retained Earnings 3.44b / Total Assets 11.0b) |
| C: 0.09 (EBIT TTM 1.03b / Avg Total Assets 11.5b) |
| D: 0.49 (Book Value of Equity 3.60b / Total Liabilities 7.38b) |
| Altman-Z'' = 2.13 = BBB |
| DSRI: 0.72 (Receivables 1.20b/1.27b, Revenue 7.46b/5.66b) |
| GMI: 1.02 (GM 21.26% / 20.81%) |
| AQI: 0.98 (AQ_t 0.47 / AQ_t-1 0.48) |
| SGI: 1.32 (Revenue 7.46b / 5.66b) |
| TATA: 0.00 (NI 646.8m - CFO 637.1m) / TA 11.0b) |
| Beneish M = -3.02 (Cap -4..+1) = AA |
As of August 26, 2026, the stock is trading at USD 57.88 with a total of 1,104,387 shares traded. Over the past week, the price has changed by +1.19%, over one month by -0.44%, over three months by +17.53% and over the past year by +28.88%.
Current recommended Stop Loss: 55.70 (which is 3.8% or 1.3 ATR below the current price).
Sonoco Products has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy SON.
- StrongBuy: 5
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 63.9 | 10.4% |
P/E Trailing = 9.1984
P/E Forward = 10.6952
P/S = 0.7618
P/B = 1.6423
P/EG = 0.2027
Revenue TTM = 7.46b USD
EBIT TTM = 1.03b USD
EBITDA TTM = 1.55b USD
Long Term Debt = 3.48b USD (from longTermDebt, last quarter)
Short Term Debt = 968.8m USD (from shortTermDebt, last quarter)
Debt = 4.97b USD (from shortLongTermDebtTotal, last quarter) + Leases 259.2m
Net Debt = 4.80b USD (calculated: Debt 4.97b - CCE 168.6m)
Enterprise Value = 10.5b USD (5.68b + Debt 4.97b - CCE 168.6m)
Interest Coverage Ratio = 5.07 (Ebit TTM 1.03b / Interest Expense TTM 203.1m)
EV/FCF = 25.98x (Enterprise Value 10.5b / FCF TTM 403.7m)
FCF Yield = 3.85% (FCF TTM 403.7m / Enterprise Value 10.5b)
FCF Margin = 5.41% (FCF TTM 403.7m / Revenue TTM 7.46b)
Net Margin = 8.67% (Net Income TTM 646.8m / Revenue TTM 7.46b)
Gross Margin = 20.81% ((Revenue TTM 7.46b - Cost of Revenue TTM 5.91b) / Revenue TTM)
Gross Margin QoQ = 20.81% (prev 20.62%)
Tobins Q-Ratio = 0.96 (Enterprise Value 10.5b / Total Assets 11.0b)
Interest Expense / Debt = 4.08% (Interest Expense 203.1m / Debt 4.97b)
Taxrate = 21.09% (172.0m / 815.5m)
NOPAT = 812.5m (EBIT 1.03b * (1 - 21.09%))
Current Ratio = 0.99 (Total Current Assets 2.79b / Total Current Liabilities 2.80b)
Debt / Equity = 1.38 (Debt 4.97b / totalStockholderEquity, last quarter 3.60b)
Debt / EBITDA = 3.10 (Net Debt 4.80b / EBITDA 1.55b)
Debt / FCF = 11.90 (Net Debt 4.80b / FCF TTM 403.7m)
Total Stockholder Equity = 3.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.64% (Net Income 646.8m / Total Assets 11.0b)
RoE = 18.34% (Net Income TTM 646.8m / Total Stockholder Equity 3.53b)
RoCE = 14.69% (EBIT 1.03b / Capital Employed (Equity 3.53b + L.T.Debt 3.48b))
RoIC = 9.06% (NOPAT 812.5m / Invested Capital 8.97b)
WACC = 5.06% (E(5.68b)/V(10.7b) * Re(6.66%) + D(4.97b)/V(10.7b) * Rd(4.08%) * (1-Tc(0.21)))
Discount Rate = 6.66% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 96.77 | Cagr: 0.26%
[DCF] Terminal Value 77.97% ; FCFF base≈299.5m ; Y1≈343.4m ; Y5≈505.3m
[DCF] Fair Price = 28.33 (EV 7.60b - Net Debt 4.80b = Equity 2.80b / Shares 98.9m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 56.19 | EPS CAGR: 3.95% | SUE: 0.45 | # QB: 0
Revenue Correlation: 25.76 | Revenue CAGR: 3.86% | SUE: 0.02 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.95 | Chg30d=-1.07% | Revisions=+15% | Analysts=10
EPS current Year (2026-12-31): EPS=5.82 | Chg30d=-0.38% | Revisions=+10% | GrowthEPS=+1.9% | GrowthRev=-0.7%
EPS next Year (2027-12-31): EPS=6.34 | Chg30d=-1.48% | Revisions=-42% | GrowthEPS=+9.0% | GrowthRev=+2.0%
[Analyst] Revisions Ratio: -7% (up=12, down=14)